本页面由Tiger Trade Technology Pte. Ltd.提供服务

Forma Therapeutics Holdings, Inc.

20.01
0.0000
成交量:- -
成交额:1,477.94万
市值:9.58亿
市盈率:-5.00
高:20.01
开:20.01
低:20.01
收:20.01
52周最高:20.68
52周最低:4.95
股本:4,786.21万
流通股本:2,376.52万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-4.0007
每股收益(LYR):-3.6531
净资产收益率:-38.26%
总资产收益率:-21.95%
市净率:2.31
市盈率(LYR):-5.48

数据加载中...

2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/10/14

重要事件披露

8-K - Current report
2022/10/14

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2022/10/14

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/14

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/14

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/14

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2022/10/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/02

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/09/01

重要事件披露

8-K - Current report
2022/08/05

重要事件披露

8-K - Current report
2022/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/07/25

重要事件披露

8-K - Current report
2022/06/09

重要事件披露

8-K - Current report
2022/06/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/26

重要事件披露

8-K - Current report
2022/05/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/06

重要事件披露

8-K - Current report
2022/03/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans